A resolution designating July 20, 2022, as "Glioblastoma Awareness Day".
SRES 614 is a Senate resolution designating July 20, 2022, as "Glioblastoma Awareness Day." It does not create new laws or funding but formally recognizes the need for greater public awareness of glioblastoma, an aggressive brain cancer with a low survival rate (6.8% at 5 years). The resolution encourages public education about the disease, honors those affected, and supports research efforts like the Glioblastoma Therapeutics Network. It serves as a symbolic gesture to highlight the urgent unmet medical needs of glioblastoma patients and caregivers.
Bill status
passed
3 of 5 stages cleared
Introduction
May 2022
Committee Review
Senate Passage
May 2022
House Passage
President
Introduced May 3, 2022
Last action May 3, 2022
Floor votes
How they voted
This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history
Actions timeline
Total actions
3
Key actions
1
Committee
0
Amendments
1
May 3, 2022
Introduced
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S2292; text: CR S2282)
upper
May 3, 2022
Upper · Passed
Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.(consideration: CR S2292; text: CR S2282)
upper
May 3, 2022
Introduced
Introduced in Senate
upper
1 primary · 6 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about SRES 614
Scope: US
Hi! I can help you understand SRES 614. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline